Cargando…

G3BP1 inhibits Cul3(SPOP) to amplify AR signaling and promote prostate cancer

SPOP, an E3 ubiquitin ligase, acts as a prostate-specific tumor suppressor with several key substrates mediating oncogenic function. However, the mechanisms underlying SPOP regulation are largely unknown. Here, we have identified G3BP1 as an interactor of SPOP and functions as a competitive inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukhopadhyay, Chandrani, Yang, Chenyi, Xu, Limei, Liu, Deli, Wang, Yu, Huang, Dennis, Deonarine, Lesa Dayal, Cyrta, Joanna, Davicioni, Elai, Sboner, Andrea, Robinson, Brian. D., Chinnaiyan, Arul M., Rubin, Mark A., Barbieri, Christopher E., Zhou, Pengbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602290/
https://www.ncbi.nlm.nih.gov/pubmed/34795264
http://dx.doi.org/10.1038/s41467-021-27024-x
_version_ 1784601546988716032
author Mukhopadhyay, Chandrani
Yang, Chenyi
Xu, Limei
Liu, Deli
Wang, Yu
Huang, Dennis
Deonarine, Lesa Dayal
Cyrta, Joanna
Davicioni, Elai
Sboner, Andrea
Robinson, Brian. D.
Chinnaiyan, Arul M.
Rubin, Mark A.
Barbieri, Christopher E.
Zhou, Pengbo
author_facet Mukhopadhyay, Chandrani
Yang, Chenyi
Xu, Limei
Liu, Deli
Wang, Yu
Huang, Dennis
Deonarine, Lesa Dayal
Cyrta, Joanna
Davicioni, Elai
Sboner, Andrea
Robinson, Brian. D.
Chinnaiyan, Arul M.
Rubin, Mark A.
Barbieri, Christopher E.
Zhou, Pengbo
author_sort Mukhopadhyay, Chandrani
collection PubMed
description SPOP, an E3 ubiquitin ligase, acts as a prostate-specific tumor suppressor with several key substrates mediating oncogenic function. However, the mechanisms underlying SPOP regulation are largely unknown. Here, we have identified G3BP1 as an interactor of SPOP and functions as a competitive inhibitor of Cul3(SPOP), suggesting a distinctive mode of Cul3(SPOP) inactivation in prostate cancer (PCa). Transcriptomic analysis and functional studies reveal a G3BP1-SPOP ubiquitin signaling axis that promotes PCa progression through activating AR signaling. Moreover, AR directly upregulates G3BP1 transcription to further amplify G3BP1-SPOP signaling in a feed-forward manner. Our study supports a fundamental role of G3BP1 in disabling the tumor suppressive Cul3(SPOP), thus defining a PCa cohort independent of SPOP mutation. Therefore, there are significantly more PCa that are defective for SPOP ubiquitin ligase than previously appreciated, and these G3BP1(high) PCa are more susceptible to AR-targeted therapy.
format Online
Article
Text
id pubmed-8602290
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-86022902021-11-19 G3BP1 inhibits Cul3(SPOP) to amplify AR signaling and promote prostate cancer Mukhopadhyay, Chandrani Yang, Chenyi Xu, Limei Liu, Deli Wang, Yu Huang, Dennis Deonarine, Lesa Dayal Cyrta, Joanna Davicioni, Elai Sboner, Andrea Robinson, Brian. D. Chinnaiyan, Arul M. Rubin, Mark A. Barbieri, Christopher E. Zhou, Pengbo Nat Commun Article SPOP, an E3 ubiquitin ligase, acts as a prostate-specific tumor suppressor with several key substrates mediating oncogenic function. However, the mechanisms underlying SPOP regulation are largely unknown. Here, we have identified G3BP1 as an interactor of SPOP and functions as a competitive inhibitor of Cul3(SPOP), suggesting a distinctive mode of Cul3(SPOP) inactivation in prostate cancer (PCa). Transcriptomic analysis and functional studies reveal a G3BP1-SPOP ubiquitin signaling axis that promotes PCa progression through activating AR signaling. Moreover, AR directly upregulates G3BP1 transcription to further amplify G3BP1-SPOP signaling in a feed-forward manner. Our study supports a fundamental role of G3BP1 in disabling the tumor suppressive Cul3(SPOP), thus defining a PCa cohort independent of SPOP mutation. Therefore, there are significantly more PCa that are defective for SPOP ubiquitin ligase than previously appreciated, and these G3BP1(high) PCa are more susceptible to AR-targeted therapy. Nature Publishing Group UK 2021-11-18 /pmc/articles/PMC8602290/ /pubmed/34795264 http://dx.doi.org/10.1038/s41467-021-27024-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Mukhopadhyay, Chandrani
Yang, Chenyi
Xu, Limei
Liu, Deli
Wang, Yu
Huang, Dennis
Deonarine, Lesa Dayal
Cyrta, Joanna
Davicioni, Elai
Sboner, Andrea
Robinson, Brian. D.
Chinnaiyan, Arul M.
Rubin, Mark A.
Barbieri, Christopher E.
Zhou, Pengbo
G3BP1 inhibits Cul3(SPOP) to amplify AR signaling and promote prostate cancer
title G3BP1 inhibits Cul3(SPOP) to amplify AR signaling and promote prostate cancer
title_full G3BP1 inhibits Cul3(SPOP) to amplify AR signaling and promote prostate cancer
title_fullStr G3BP1 inhibits Cul3(SPOP) to amplify AR signaling and promote prostate cancer
title_full_unstemmed G3BP1 inhibits Cul3(SPOP) to amplify AR signaling and promote prostate cancer
title_short G3BP1 inhibits Cul3(SPOP) to amplify AR signaling and promote prostate cancer
title_sort g3bp1 inhibits cul3(spop) to amplify ar signaling and promote prostate cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602290/
https://www.ncbi.nlm.nih.gov/pubmed/34795264
http://dx.doi.org/10.1038/s41467-021-27024-x
work_keys_str_mv AT mukhopadhyaychandrani g3bp1inhibitscul3spoptoamplifyarsignalingandpromoteprostatecancer
AT yangchenyi g3bp1inhibitscul3spoptoamplifyarsignalingandpromoteprostatecancer
AT xulimei g3bp1inhibitscul3spoptoamplifyarsignalingandpromoteprostatecancer
AT liudeli g3bp1inhibitscul3spoptoamplifyarsignalingandpromoteprostatecancer
AT wangyu g3bp1inhibitscul3spoptoamplifyarsignalingandpromoteprostatecancer
AT huangdennis g3bp1inhibitscul3spoptoamplifyarsignalingandpromoteprostatecancer
AT deonarinelesadayal g3bp1inhibitscul3spoptoamplifyarsignalingandpromoteprostatecancer
AT cyrtajoanna g3bp1inhibitscul3spoptoamplifyarsignalingandpromoteprostatecancer
AT davicionielai g3bp1inhibitscul3spoptoamplifyarsignalingandpromoteprostatecancer
AT sbonerandrea g3bp1inhibitscul3spoptoamplifyarsignalingandpromoteprostatecancer
AT robinsonbriand g3bp1inhibitscul3spoptoamplifyarsignalingandpromoteprostatecancer
AT chinnaiyanarulm g3bp1inhibitscul3spoptoamplifyarsignalingandpromoteprostatecancer
AT rubinmarka g3bp1inhibitscul3spoptoamplifyarsignalingandpromoteprostatecancer
AT barbierichristophere g3bp1inhibitscul3spoptoamplifyarsignalingandpromoteprostatecancer
AT zhoupengbo g3bp1inhibitscul3spoptoamplifyarsignalingandpromoteprostatecancer